ecrin-mdr-crcClinical2017Lymphoma, T-CellRefractory Adult T-Cell Leukemia/LymphomaLeukemiaNK-Cell Lymphoma, UnclassifiableLymphoma, T-Cell, PeripheralMycosesRefractory Enteropathy-Associated T-Cell LymphomaBlastic Plasmacytoid Dendritic Cell NeoplasmRefractory Angioimmunoblastic T-cell LymphomaLeukemia, T-CellLymphoma, Non-HodgkinRecurrent Angioimmunoblastic T-cell LymphomaMycosis FungoidesRefractory Nasal Type Extranodal NK/T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedHTLV-1 InfectionRefractory Anaplastic Large Cell LymphomaLeukemia-Lymphoma, Adult T-CellEnteropathy-Associated T-Cell LymphomaHepatosplenic T-Cell LymphomaRecurrent Adult T-Cell Leukemia/LymphomaRecurrent Mycosis FungoidesImmunoblastic LymphadenopathyIntestinal DiseasesRefractory Mycosis FungoidesPrimary Systemic Anaplastic Large Cell Lymphoma, ALK-NegativeRecurrent Enteropathy-Associated T-Cell LymphomaLymphomaRecurrent Anaplastic Large Cell LymphomaLymphoma, Extranodal NK-T-CellLymphoma, Large-Cell, AnaplasticLeukemiaMycosesRefractory Nasal Type Extranodal Nk/t-cell LymphomaBlastic Plasmacytoid Dendritic Cell NeoplasmRefractory Angioimmunoblastic T-cell LymphomaRefractory Enteropathy-associated T-cell LymphomaLymphoma, Large-cell, AnaplasticRecurrent Angioimmunoblastic T-cell LymphomaMycosis FungoidesLeukemia-lymphoma, Adult T-cellLymphoma, T-cellPrimary Systemic Anaplastic Large Cell Lymphoma, Alk-negativeLeukemia, T-cellRefractory Peripheral T-cell Lymphoma, Not Otherwise SpecifiedRefractory Anaplastic Large Cell LymphomaHepatosplenic T-cell LymphomaLymphoma, T-cell, PeripheralRecurrent Mycosis FungoidesRefractory Adult T-cell Leukemia/lymphomaImmunoblastic LymphadenopathyLymphoma, Extranodal Nk-t-cellRefractory Mycosis FungoidesIntestinal DiseasesLymphomaRecurrent Anaplastic Large Cell LymphomaEnteropathy-associated T-cell LymphomaHtlv-1 InfectionRecurrent Enteropathy-associated T-cell LymphomaRecurrent Adult T-cell Leukemia/lymphomaLymphoma, Non-hodgkinNk-cell Lymphoma, UnclassifiableInterventionalhttps://newmdr.ecrin.org/Study/2238422United States5NivolumabECRIN MDRTerminatedfalseNivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell LymphomaThis phase II trial studies how well nivolumab works in treating patients with peripheral T-cell lymphoma that has come back after a period of improvement or that does not respond to treatment. Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells.2017-05-152238422NCT03075553